Enhancement of Cancer Therapeutic Efficacy through Combined Drug Treatment Using a Proteasome Inhibitor and Other Drugs
博士 === 國立臺灣海洋大學 === 生命科學暨生物科技學系 === 105 === Genomic DNA is consistently threatened by both endogenous and exogenous genotoxic agents. To preserve DNA integrity, cells have evolved sophisticated repair systems. Improper to fulfill these tasks may lead to predisposition of malignant transformation or...
Main Authors: | Shen, Yung-Chi, 沈永吉 |
---|---|
Other Authors: | Hsu, Todd |
Format: | Others |
Language: | en_US |
Published: |
2017
|
Online Access: | http://ndltd.ncl.edu.tw/handle/h3vf7a |
Similar Items
-
Synergistic effects of combining proteasome inhibitors with chemotherapeutic drugs in lung cancer cells
by: Linda Sooman, et al.
Published: (2017-11-01) -
Polymer micelle formulation for the proteasome inhibitor drug carfilzomib: Anticancer efficacy and pharmacokinetic studies in mice.
by: Ji Eun Park, et al.
Published: (2017-01-01) -
Trypanocidal activity of the proteasome inhibitor and anti-cancer drug bortezomib
by: Wang Xia, et al.
Published: (2009-07-01) -
Nanocarriers in the Enhancement of Therapeutic Efficacy of Natural Drugs
by: Xiuling Li, et al.
Published: (2021-07-01) -
Treatment of Plasmodium chabaudi Parasites with Curcumin in Combination with Antimalarial Drugs: Drug Interactions and Implications on the Ubiquitin/Proteasome System
by: Zoraima Neto, et al.
Published: (2013-01-01)